Tag: multi-criteria decision analysis

Valuing Rare Disease Medicines – We Can Do Better

London, United Kingdom – Many rare diseases, often severe and life-threatening, cannot be treated. The small numbers of patients affected make it time-consuming and costly to compile evidence about treatments. Organisations that pay for health care recognise that a special approach

Posted in Brief Report, Value in Health Tagged with: , , , ,

Does the Future Belong to MCDA?

London, UK – A key challenge for health care decision makers is balancing the multiplicity of medical, social, and economic factors that have a bearing on their choices. These factors, and the importance attached to them, often vary from one decision to

Posted in ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: